Medicines for rare diseases

    Discover
    ORPHELIA Pharma

    Development of essential medicines in the field of pediatric and rare diseases.

    Read more

    Discover
    Products & Projects

    Focus on deadly epileptic childhood syndromes and refractory and relapsed pediatric cancers.

    therapeutics areas
    Our products

    Latest news

    Visit our news flow to access our press release and latest news.

    21 July 2021

    ORPHELIA Pharma and Clinigen sign an agreement to supply Kigabeq®

    Read More
    16 June 2021

    European Patent covering Kimozo®

    Read More
    4 May 2021

    Inclusion of the first patient in the TEMOkids pediatric clinical trial

    Read More